Abstract
Variations in the human mu-opioid receptor gene have driven exploration of their biochemical, physiological and pathological relevance. We investigated the existence of variations in the nonhuman primate mu-opioid receptor gene to determine whether nonhuman primates can model genotype/phenotype associations of relevance to humans. Similar to the A118G single nucleotide polymorphism (SNP) in the human mu-opioid receptor gene, a SNP discovered in the rhesus monkey mu-opioid receptor gene (C77G) alters an amino acid in the N-terminal arm of the receptor (arginine for proline at position 26). Two mu-opioid receptor coding regions isolated from a single heterozygous (C77/G77) rhesus monkey brain were expressed in HEK-293 cells and characterized in radioreceptor assays. Paralleling the findings of increased affinity of β-endorphin by the A118G allele in the human, the rhesus monkey mu-opioid receptor protein derived from the G77-containing clone demonstrated a 3.5-fold greater affinity for β-endorphin than the receptor derived from the C77-containing clone. An assay developed to assess the incidence of the C77G SNP in a behaviorally and physiologically characterized cohort of rhesus monkeys (n=32) indicated that 44% were homozygous for C77-containing alleles, 50% were heterozygous and 6% were homozygous for G77-containing alleles. The presence of G77-containing alleles was associated with significantly lower basal and ACTH-stimulated plasma cortisol levels (P<0.03–0.05 and P<0.02, respectively) and a significantly higher aggressive threat score (P<0.05) in vivo. In a cohort of 20 monkeys, a trend towards an inverse correlation between aggressive threat and plasma cortisol levels was observed. The findings suggest that mu-opioid receptor haplotypes in monkeys can contribute to individual variability in stress response and related aggression. The data support the use of nonhuman primates to investigate mu-opioid receptor genotype/phenotype relations of relevance to humans.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Hoehe MR, Kopke K, Wendel B, Rohde K, Flachmeier C, Kidd KK et al. Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet 2000; 9: 2895–2908.
Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998; 95: 9608–9613.
Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S et al. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 2002; 26: 106–114.
Miller GM, Yatin SM, De La GR, Goulet M, Madras BK . Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Brain Res Mol Brain Res 2001; 87:124–143.
Miller GM, de la Garza II R, Novak MA, Madras BK . Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders. Mol Psychiatry 2001; 6: 50–58.
Miller GM, Madras BK . Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 2002; 7:44–55.
Miller GM, Madras BK . Cloning of rhesus monkey TAR-1, a novel G-protein-linked receptor for “trace” amines. Soc Neurosci Abstr 2002; 28: 10.1.
Grosch S, Niederberger E, Lotsch J, Skarke C, Geisslinger G . A rapid screening method for a single nucleotide polymorphism (SNP) in the human MOR gene. Br J Clin Pharmacol 2001; 52: 711–714.
Kreek MJ . Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem Res 1996; 21: 1469–1488.
Pasquali R, Vicennati V . Activity of the hypothalamic–pituitary–adrenal axis in different obesity phenotypes. Int J Obes Relat Metab Disord 2000; 24 (Suppl 2): S47–S49.
Sapolsky RM . Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp Gerontol 1999; 34: 721–732.
Sapolsky RM . Stress hormones: good and bad. Neurobiol Dis 2000; 7: 540–542.
Becker A, Schroder H, Brosz M, Grecksch G, Schneider-Stock R . Differences between two substrains of AB mice in the opioid system. Pharmacol Biochem Behav 1997; 58: 763–766.
Benton D . Mu and kappa opiate receptor involvement in agonistic behaviour in mice. Pharmacol Biochem Behav 1985; 23: 871–876.
Gwynn GJ, Domino EF . Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity. J Pharmacol Exp Ther 1984; 231: 306–311.
Giraud O, Cervo L, Grignaschi G, Samanin R . Activation of mu opioid receptors in the nucleus raphe dorsalis blocks apomorphine-induced aggression in rats: serotonin appears not to be involved. Brain Res 1989; 488: 174–179.
Meyer ME, Meyer ME . Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities. Pharmacol Biochem Behav 1993; 45: 315–320.
Meyer ME, McLaurin BI, Allen M, Meyer ME . Biphasic effects of intraaccumbens mu-opioid peptide agonist DAMGO on locomotor activities. Pharmacol Biochem Behav 1994; 47: 827–831.
Kalin NH, Larson C, Shelton SE, Davidson RJ . Asymmetric frontal brain activity, cortisol, and behavior associated with fearful temperament in rhesus monkeys. Behav Neurosci 1998; 112: 286–292.
Kalin NH . Primate models to understand human aggression. J Clin Psychiatry 1999; 60 (Suppl 15): 29–32.
McBurnett K, Lahey BB, Rathouz PJ, Loeber R . Low salivary cortisol and persistent aggression in boys referred for disruptive behavior. Arch Gen Psychiatry 2000; 57: 38–43.
Pajer K, Gardner W, Rubin RT, Perel J, Neal S . Decreased cortisol levels in adolescent girls with conduct disorder. Arch Gen Psychiatry 2001; 58: 297–302.
Jordan BA, Cvejic S, Devi LA . Opioids and their complicated receptor complexes. Neuropsychopharmacology 2000; 23: S5–S18.
Suzuki S, Carlos MP, Chuang LF, Torres JV, Doi RH, Chuang RY . Methadone induces CCR5 and promotes AIDS virus infection. FEBS Lett 2002; 519: 173–177.
Bot G, Blake AD, Li S, Reisine T . Mutagenesis of a single amino acid in the rat mu-opioid receptor discriminates ligand binding. J Neurochem 1998; 70: 358–365.
Hofmann K, Stoffel W . TMbase—A database of membrane spanning protein segments. Biol Chem 1993; 347: 166.
Blom N, Gammeltoft S, Brunak S . Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 1999; 294: 1351–1362.
Kreegipuu A, Blom N, Brunak S . PhosphoBase, a database of phosphorylation sites: release 2.0. Nucleic Acids Res 1999; 27: 237–239.
Tiefenbacher S, Novak MA, Jorgensen MJ, Meyer JS . Physiological correlates of self-injurious behavior in captive, socially-reared rhesus monkeys. Psychoneuroendocrinology 2000; 25: 799–817.
Tiefenbacher S, Novak MA, Marinos LM, Chase WK, Miller JA, Meyer JS . Altered hypothalamic-pituitary-adrenocortical function in rhesus monkeys (Macaca mulatta) with self-injurous behaviour. Psychoneuroendocrinology 2003; doi: 10.1016/S0306-4530(03)00068-4.
Acknowledgements
We thank Amber Pouliot for her excellent technical assistance and Jennifer Carter for assistance in manuscript preparation.
Author information
Authors and Affiliations
Corresponding author
Additional information
Support: DA06303, DA00304, DA15305, RR00168 and RR11122.
Rights and permissions
About this article
Cite this article
Miller, G., Bendor, J., Tiefenbacher, S. et al. A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression. Mol Psychiatry 9, 99–108 (2004). https://doi.org/10.1038/sj.mp.4001378
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.mp.4001378
Keywords
This article is cited by
-
Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons
Molecular Psychiatry (2020)
-
Non-invasive genotyping with a massively parallel sequencing panel for the detection of SNPs in HPA-axis genes
Scientific Reports (2018)
-
Common marmoset (Callithrix jacchus) personality, subjective well-being, hair cortisol level and AVPR1a, OPRM1, and DAT genotypes
Scientific Reports (2018)
-
Large-scale polymorphism discovery in macaque G-protein coupled receptors
BMC Genomics (2013)
-
The genetics of the opioid system and specific drug addictions
Human Genetics (2012)


